Skip to main content

Table 5 Comparison of MAP and HR at different time points

From: Effects of intravenous lidocaine, dexmedetomidine, and their combination on IL-1, IL-6 and TNF-α in patients undergoing laparoscopic hysterectomy: a prospective, randomized controlled trial

Variables

Groups

T0

T1

T2

MAP (mmHg)

Group C

79.2 ± 8.2

73.9 ± 4.3

77.1 ± 5.1

Group L

78.6 ± 8.5

73.3 ± 5.1

74.2 ± 4.7*

Group D

81.4 ± 7.1

72.2 ± 5.9

73.6 ± 4.4*

Group LD

80.1 ± 6.2

71.1 ± 4.5

71.5 ± 4.6*#

HR (bpm)

Group C

74.3 ± 9.0

66.9 ± 6.3

71.8 ± 5.7

Group L

72.6 ± 8.5

66.3 ± 6.6

68.6 ± 7.7

Group D

74.8 ± 9.1

60.4 ± 5.2*#

60.9 ± 5.4*#

Group LD

73.8 ± 9.2

60.0 ± 5.0*#

60.2 ± 4.8*#

  1. Data are presented as mean ± standard deviation (SD)
  2. T0 baseline, T1 at the end of surgery, T2 2 h after surgery, C control, L lidocaine, D dexmedetomidine, LD lidocaine and dexmedetomidine combination
  3. P < 0.05 compared with T0, *P < 0.05 versus group C, #P < 0.05 versus group L